MX2011010191A - Peptidos c6orf167 y vacunas que continen los mismos. - Google Patents
Peptidos c6orf167 y vacunas que continen los mismos.Info
- Publication number
- MX2011010191A MX2011010191A MX2011010191A MX2011010191A MX2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A
- Authority
- MX
- Mexico
- Prior art keywords
- peptides
- c6orf167
- methods
- antigen
- inducing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21170009P | 2009-04-01 | 2009-04-01 | |
| PCT/JP2010/002352 WO2010113495A1 (en) | 2009-04-01 | 2010-03-31 | C6orf167 peptides and vaccines containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011010191A true MX2011010191A (es) | 2011-11-29 |
Family
ID=42827803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011010191A MX2011010191A (es) | 2009-04-01 | 2010-03-31 | Peptidos c6orf167 y vacunas que continen los mismos. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120128705A1 (enExample) |
| EP (1) | EP2414383A4 (enExample) |
| JP (1) | JP5728759B2 (enExample) |
| KR (1) | KR20120034605A (enExample) |
| CN (2) | CN102448980B (enExample) |
| AU (1) | AU2010231381A1 (enExample) |
| BR (1) | BRPI1013384A2 (enExample) |
| CA (1) | CA2757210A1 (enExample) |
| IL (1) | IL215268A0 (enExample) |
| MX (1) | MX2011010191A (enExample) |
| RU (1) | RU2011144088A (enExample) |
| SG (2) | SG2014011423A (enExample) |
| TW (1) | TW201100090A (enExample) |
| WO (1) | WO2010113495A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007013671A2 (en) | 2005-07-27 | 2007-02-01 | Oncotherapy Science, Inc. | Method of diagnosing esophageal cancer |
| CN102884190B (zh) | 2010-03-11 | 2016-03-23 | 肿瘤疗法科学股份有限公司 | Hjurp肽及包含它们的疫苗 |
| JP2013542711A (ja) * | 2010-08-19 | 2013-11-28 | オンコセラピー・サイエンス株式会社 | がんの治療および診断の標的遺伝子としてのC6orf167 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1273499A (en) * | 1997-10-24 | 1999-05-17 | Human Genome Sciences, Inc. | 148 human secreted proteins |
| CN1351069A (zh) * | 2000-10-26 | 2002-05-29 | 上海博德基因开发有限公司 | 一种新的多肽——鼠的同ampa受体相互作用的蛋白grip12.54和编码这种多肽的多核苷酸 |
| US7919467B2 (en) * | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| CN101139392B (zh) * | 2002-09-12 | 2012-12-26 | 肿瘤疗法科学股份有限公司 | Kdr肽和包括该肽的疫苗 |
| JP4628208B2 (ja) * | 2004-08-10 | 2011-02-09 | オンコセラピー・サイエンス株式会社 | Cxadrl1またはgcud1タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン |
| DK2325306T3 (en) * | 2005-02-25 | 2014-03-03 | Oncotherapy Science Inc | Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide |
| WO2007013671A2 (en) * | 2005-07-27 | 2007-02-01 | Oncotherapy Science, Inc. | Method of diagnosing esophageal cancer |
| EP2295571A1 (en) * | 2005-07-27 | 2011-03-16 | Oncotherapy Science, Inc. | Method of diagnosing small cell lung cancer |
| JP5409658B2 (ja) * | 2008-03-13 | 2014-02-05 | セレラ コーポレーション | 静脈血栓症に関連した遺伝子多型、その検出方法および使用 |
-
2010
- 2010-03-30 TW TW099109539A patent/TW201100090A/zh unknown
- 2010-03-31 CN CN201080024056.0A patent/CN102448980B/zh not_active Expired - Fee Related
- 2010-03-31 WO PCT/JP2010/002352 patent/WO2010113495A1/en not_active Ceased
- 2010-03-31 JP JP2011542381A patent/JP5728759B2/ja not_active Expired - Fee Related
- 2010-03-31 AU AU2010231381A patent/AU2010231381A1/en not_active Abandoned
- 2010-03-31 EP EP10758274.4A patent/EP2414383A4/en not_active Withdrawn
- 2010-03-31 BR BRPI1013384A patent/BRPI1013384A2/pt not_active IP Right Cessation
- 2010-03-31 SG SG2014011423A patent/SG2014011423A/en unknown
- 2010-03-31 CN CN201510111822.1A patent/CN104774260A/zh active Pending
- 2010-03-31 SG SG2011071370A patent/SG174998A1/en unknown
- 2010-03-31 CA CA2757210A patent/CA2757210A1/en not_active Abandoned
- 2010-03-31 KR KR1020117025871A patent/KR20120034605A/ko not_active Withdrawn
- 2010-03-31 RU RU2011144088/10A patent/RU2011144088A/ru unknown
- 2010-03-31 MX MX2011010191A patent/MX2011010191A/es active IP Right Grant
- 2010-03-31 US US13/260,900 patent/US20120128705A1/en not_active Abandoned
-
2011
- 2011-09-21 IL IL215268A patent/IL215268A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010113495A1 (en) | 2010-10-07 |
| SG174998A1 (en) | 2011-11-28 |
| EP2414383A4 (en) | 2013-07-31 |
| TW201100090A (en) | 2011-01-01 |
| EP2414383A1 (en) | 2012-02-08 |
| CN104774260A (zh) | 2015-07-15 |
| BRPI1013384A2 (pt) | 2016-03-29 |
| CA2757210A1 (en) | 2010-10-07 |
| US20120128705A1 (en) | 2012-05-24 |
| CN102448980A (zh) | 2012-05-09 |
| RU2011144088A (ru) | 2013-05-10 |
| JP5728759B2 (ja) | 2015-06-03 |
| KR20120034605A (ko) | 2012-04-12 |
| AU2010231381A1 (en) | 2011-11-03 |
| CN102448980B (zh) | 2015-04-15 |
| JP2012522488A (ja) | 2012-09-27 |
| IL215268A0 (en) | 2011-11-30 |
| SG2014011423A (en) | 2014-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010014044A (es) | Peptidos de epitope cdca1 y vacunas que contienen los mismos. | |
| PH12019502194A1 (en) | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer | |
| GB201004575D0 (en) | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers | |
| MX362912B (es) | Péptidos ube2t y vacunas que incluyen los mismos. | |
| BR112015021828A2 (pt) | Peptídeos de kntc2 e vacinas que contêm os mesmos | |
| CR20210464A (es) | Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido en carcinoma del pulmón amicrocítico (nsclc) | |
| WO2019197567A3 (en) | Antigenic peptides for prevention and treatment of cancer | |
| MX2011012013A (es) | Peptidos ttk y vacunas que incluyen los mismos. | |
| MX337756B (es) | Peptido de epitope hig2 y urlc10 y vacunas que contienen el mismo. | |
| PH12014500720A1 (en) | Topk peptides and vaccines including the same | |
| MX2011010191A (es) | Peptidos c6orf167 y vacunas que continen los mismos. | |
| MX2012008657A (es) | Peptidos melk modificados y vacunas que contienen los mismos. | |
| EP4219525A3 (en) | Foxm1-derived peptide, and vaccine including same | |
| MX2022006022A (es) | Peptido derivado de depdc1 y vacuna que lo contiene. | |
| MX2015007015A (es) | Peptidos sema5b y vacunas que contienen los mismos. | |
| EP4353321A3 (en) | Koc1-derived peptide and vaccine including same | |
| BR112013005448A2 (pt) | peptídeos de ttll4 e vacinas contendo os mesmos. | |
| EP3848383A3 (en) | Urlc10-derived peptide and vaccine containing same | |
| SG10201900879PA (en) | Cdca1-derived peptide and vaccine containing same | |
| BR112012013371A2 (pt) | peptídeo mybl2 e vacinas contendo os mesmos. | |
| EP2513136A4 (en) | PEPTIDES TMEM22 AND VACCINES COMPRISING THEM | |
| MX344579B (es) | Peptidos hjurp y vacunas que incluyen los mismos. | |
| MX2012011666A (es) | Peptidos cluap1 y vacunas que incluyen los mismos. | |
| MY194653A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| MY194244A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |